Nicotine and Breast Cancer
- Taking vitamin E and vitamin C supplements may not make cancer less likely, a new study shows. That finding comes from the Physicians’ Health Study II, which recently showed that taking vitamin C and vitamin E supplements may not lower the risk of heart attack or stroke. Researchers have now analyzed study data on cancer
Full Post: Vitamin C, E Pills Fail to Prevent Cancer
(Ivanhoe Newswire) — Nicotine may play a role in breast tumor development and metastases according to a new study.
Researchers at the Beth Israel Deaconess Medical Center in Boston found through a series of tests that nicotine can potentially increase breast cancer cell growth and migration. Breast epithelial-like MCF10A cells and cancerous MCF7 cells both express several subunits of nicotine receptor known as nAChR. When bound these cells initiate a signaling process that researchers believe may be involved in tumor growth and metastases.
Trials confirm that nicotine isn’t a conventional carcinogen, but that it combines with other yet to be determined factors to promote tumor growth. “In vitro and in vivo tests showed that no metastasis occurs with the administration of nicotine alone,” lead author Chang Yan Chen, Ph.D., M.D., researcher at Beth Israel Deaconess Medical Center, was quoted as saying. “At this point we can only suggest that nicotine potentiates the growth-related process.”
Dr. Chen and his colleagues hope to conduct more studies to further explore the effects of nicotine exposure on breast cancer initiation and development.
SOURCE: Cancer Research, 2008;68:8473-8481
Source
Related Posts:
NEW YORK - Nicotine, whether absorbed by smoking cigarettes or inhaling second-hand smoke, may promote tumor growth and the spread of breast cancer, a study found. Nicotine made breast cancer cells more likely to multiply and migrate in laboratory tests, according to the study published in yesterday’s issue of the journal Cancer Research. Such evidence also
Full Post: Nicotine found to spur breast cancer growth
--------------------------------------------------------------------------------------------
The Cure Our Children Foundation, a nonprofit charitable foundation dedicated to children, announced today that the U.S. Food and Drug Administration (FDA) has approved the Orphan Drug Designation of the foundation’s unique drug product for children with Ewing’s Sarcoma cancer. The efforts to develop this drug were made possible by the generous volunteers and researchers
Full Post: FDA grants orphan drug status to new ‘Trojan Horse’ like Ewing’s Sarcoma drug
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - A mastectomy is prudent when breast cancer returns after a lumpectomy, because survival rates are better than with another lumpectomy, according to a new report. “We were surprised to find that so many women in our study — almost a quarter of them — had received another lumpectomy rather than a
Full Post: Lumpectomy not advised if breast cancer returns
--------------------------------------------------------------------------------------------
Do you know that breast cancer is the most common cancer among women? Breast cancer is also the second leading cause of cancer related deaths in American women. Most cases of breast cancer are diagnosed when a mammogram reveals a lump. A change in the texture of breast tissue can also be a warning sign
Full Post: Nolvadex PCT
--------------------------------------------------------------------------------------------
WEDNESDAY, Nov. 5 (HealthDay News) — In a genetics first, researchers report that they have decoded the complete DNA sequence of a person with acute myelogenous leukemia. There were some surprises — eight previously unknown mutations, along with two already identified genetic alterations, were associated with the blood cell cancer. But more
Full Post: First-Ever Mapping of Cancer Patient’s Genome